Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis

OBJECTIVE: To assess the safety and efficacy of lenabasum in diffuse cutaneous systemic sclerosis (dcSSc). METHODS: A randomized, double‐blind, placebo‐controlled, phase II study was conducted at 9 SSc clinics in the US. Adults with dcSSc of ≤6 years’ duration who were receiving stable standard‐of‐c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arthritis Rheumatol
Asıl Yazarlar: Spiera, Robert, Hummers, Laura, Chung, Lorinda, Frech, Tracy M., Domsic, Robyn, Hsu, Vivien, Furst, Daniel E., Gordon, Jessica, Mayes, Maureen, Simms, Robert, Lafyatis, Robert, Martyanov, Viktor, Wood, Tammara, Whitfield, Michael L., Constantine, Scott, Lee, Elizabeth, Dgetluck, Nancy, White, Barbara
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Systemic Sclerosis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497006/
https://ncbi.nlm.nih.gov/pubmed/32336038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41294
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller